Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details)

v3.22.2.2
Fair Value Measurements and Hierarchy - Carrying Value of Financial Instruments (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Fair Value Measurements and Hierarchy            
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor Predecessor Successor Predecessor
Cash $ 140,477,586 $ 63,145,379 $ 16,322,893   $ 63,145,379 $ 16,322,893
Restricted Cash 356,286 753,920 $ 223,872   753,920 $ 223,872
Clinic Fees and Insurance Receivables, Net 1,090,104 1,931,291     1,931,291  
Other Receivables 726,903 261,935     261,935  
Accounts Payable and Accrued Expenses 17,730,683 20,693,070     20,693,070  
Liability for warrants $ 11,382,826 $ 5,429,009     $ 5,429,009